SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Sep 17, 2019

InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: Sept. 17, 2019 · CIK: 0001433607 · Accession: 0001493152-19-014221

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-233432

Date
August 23, 2019
Author
Chief
Form
CORRESP
Company
InspireMD, Inc. (NSPR) (CIK 0001433607)

Letter

InspireMD, Inc.

Menorat Hamaor St.

Tel Aviv, Israel 6744832

September 17, 2019

VIA EDGAR

Division of Corporation Finance

Securities and Exchange Commission

Washington, D.C. 20549

Attention: Mr. Geoff Kruczek

Ms. Amanda Ravitz

Re: InspireMD, Inc.

Registration Statement on Form S-1, originally filed on August 23, 2019

File No. 333-233432, as amended (the “Registration Statement”)

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InspireMD, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 5:00 p.m., Eastern Time, on September 19, 2019, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

Very
truly yours,
InspireMD,
Inc.

Show Raw Text
CORRESP
1
filename1.htm

InspireMD,
Inc.

4
Menorat Hamaor St.

Tel
Aviv, Israel 6744832

September
17, 2019

VIA
EDGAR

Division
of Corporation Finance

Securities
and Exchange Commission

Washington,
D.C. 20549

Attention:
Mr. Geoff Kruczek

                 Ms.
Amanda Ravitz

    Re:
    InspireMD,
    Inc.

    Registration
    Statement on Form S-1, originally filed on August 23, 2019

    File
    No. 333-233432, as amended (the “Registration Statement”)

Ladies
and Gentlemen:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, InspireMD, Inc. (the “Company”)
hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective
at 5:00 p.m., Eastern Time, on September 19, 2019, or as soon thereafter as practicable.

Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel,
Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

    Very
    truly yours,

    InspireMD,
    Inc.

    By:

    /s/
    Craig Shore

    Craig
    Shore

    Chief
    Financial Officer